The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

Exposure to SARS-CoV-2 infection in utero was associated with an increased risk of neurodevelopmental diagnoses among ...

Children born to mothers who contracted COVID-19 during pregnancy face a 29% higher likelihood of developmental disorders by ...

Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...

Stream Connecticut News for free, 24/7, wherever you are. The findings may increase scrutiny about the usefulness of the treatment, molnupiravir, which was one of the first Covid drugs available to ...

In earlier laboratory experiments, researchers had observed that mRNA vaccines improve the effectiveness of cancer drugs such ...

Pharmaceutical company Merck announced Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus. The company said it ...

WASHINGTON, D.C. — An advisory board for the Food and Drug Administration (FDA) voted 13-10 to authorize the use of Merck's COVID-19 anti-viral pill. The company is seeking an emergency use ...

The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...

Sept 11 (Reuters) - U.S. drugmaker Merck & Co Inc (MRK.N), opens new tab has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database ...

Belén Garijo, who steered Merck KGaA through the COVID-19 pandemic, will step down as CEO of the German healthcare and electronics conglomerate. Garijo will end her five-year tenure as planned by the ...